MétaCan
Menu
Back to cohort

Baseline results of a living systematic review for COVID-19 clinical trial registrations

2020· preprint· en· W3033756437 on OpenAlexaff
Brittany Maguire, Alistair R.D. McLean, Sumayyah Rashan, Emilia Antonio, Jayshree Bagaria, Zineb Bentounsi, Matthew Brack, Fiona Caldwell, Verena I. Carrara, Barbara Wanjiru Citarella, Prabin Dahal, Vitalis Fambombi Feteh, Marius H.B. Guérin, Kalynn Kennon, Kathinka Bilton Lahaut, Gerald Jamberi Makuka, Roland Cheofor Ngu, Sopuruchukwu Obiesie, Caitlin Richmond, Sauman Singh-Phulgenda, Samantha Strudwick, Carina S.B. Tyrrell, Austin Schwinn, D.P. King, Paul N. Newton, Ric N. Price, Laura Merson, Kasia Stepniewska, Philippe J. Guérin

Bibliographic record

VenueWellcome Open Research · 2020
Typepreprint
Languageen
FieldDecision Sciences
TopicMeta-analysis and systematic reviews
Canadian institutionsUniversity of Toronto
FundersWellcome TrustNational Institute for Health and Care ResearchBill and Melinda Gates Foundation
KeywordsMedicinePsychological interventionFamily medicineClinical trialInternal medicineNursing

Abstract

fetched live from OpenAlex

Background: Since the coronavirus disease 2019 (COVID-19) outbreak was first reported in December 2019, many independent trials have been planned that aim to answer similar questions. Tools allowing researchers to review studies already underway can facilitate collaboration, cooperation and harmonisation. The Infectious Diseases Data Observatory (IDDO) has undertaken a living systematic review (LSR) to provide an open, accessible and frequently updated resource summarising characteristics of COVID-19 study registrations. Methods: Review of all eligible trial records identified by systematic searches as of 3 April 2020 and initial synthesis of clinical study characteristics were conducted. In partnership with Exaptive , an open access, cloud-based knowledge graph has been created using the results. Results: There were 728 study registrations which met eligibility criteria and were still active. Median (25 th , 75 th percentile) sample size was 130 (60, 400) for all studies and 134 (70, 300) for RCTs. Eight lower middle and low income countries were represented among the planned recruitment sites. Overall 109 pharmacological interventions or advanced therapy medicinal products covering 23 drug categories were studied. Majority (57%, 62/109) of them were planned only in one study arm, either alone or in combination with other interventions. There were 49 distinct combinations studied with 90% (44/49) of them administered in only one or two study arms. The data and interactive platform are available at https://iddo.cognitive.city/ . Conclusions: Baseline review highlighted that the majority of investigations in the first three months of the outbreak were small studies with unique treatment arms, likely to be unpowered to provide solid evidence. The continued work of this LSR will allow a more dependable overview of interventions tested, predict the likely strength of evidence generated, allow fast and informative filtering of relevant trials for specific user groups and provide the rapid guidance needed by investigators and funders to avoid duplication of efforts.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.165
metaresearch head score (Gemma)0.525
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.835
Threshold uncertainty score0.873

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.1650.525
Meta-epidemiology (narrow)0.0030.003
Meta-epidemiology (broad)0.0140.017
Bibliometrics0.0250.036
Science and technology studies0.0030.002
Scholarly communication0.0090.010
Open science0.0050.007
Research integrity0.0060.006
Insufficient payload (model declined to judge)0.1100.014

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.978
GPT teacher head0.741
Teacher spread0.237 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designSystematic review
DomainMethods
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations30
Published2020
Admission routes1
Has abstractyes

Explore more

Same venueWellcome Open ResearchSame topicMeta-analysis and systematic reviewsFrench-language works237,207